The new EVP of Business Development is Cat Stace

It is with great pleasure that we welcome Cat Stace, Executive Vice President of Business Development, to Kuano.

Prior to Kuano, Cat was EVP Business Development for Domainex, during which the business more than doubled in size. Cat began her career establishing therapeutic platforms and discovery programmes for Isogenica and Bicycle Therapeutics, becoming inventor of core industrial technology and clinical candidates. Cat has also consulted for a variety of biotech and healthtech companies.

Cat has 18 years experience in the drug discovery industry, specialising in biotechnology platforms and commercialisation. She has held strategic technology and business development roles in biotechnology, consultancy and CRO organisations, covering small molecule therapeutics, peptides, healthtech and engineering.

Previous
Previous

Kuano is delighted to have recognised as one of the Top21 companies to watch in 2024

Next
Next

Dr Ted Witek joins Kuano’s board of directors